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Abstract 
The use of telehealth in healthcare has grown in recent years; however, little is known 
about the effectiveness of this delivery method in the management of Type 2 diabetes 
mellitus (T2DM). Guided by the chronic care model and telehealth in chronic disease 
model, the purpose of this systematic literature review was to explore evidence related to 
lowering hemoglobin A1c levels and managing T2DM using telehealth in the outpatient 
setting. The practice-focused questions explored telehealth interventions used in T2DM 
management and their effectiveness. The Joanna Briggs Institute (JBI) method for 
conducting systematic literature reviews was the process, and data were compiled using 
the PRISMA evidence-based minimum set for reporting. Eighteen studies met the 
inclusion criteria for this project. Data were extracted, analyzed, and synthesized using 
JBI tools for data extraction and critical appraisal. Article appraisals revealed numerous 
telehealth interventions for management of T2DM including telephone, Internet-based, 
clinical video, remote monitoring, and smart phones/applications. Overall, telehealth 
interventions showed statistically significant improvement in the hemoglobin A1c levels 
of participants compared to traditional outpatient care. Success of the interventions is 
associated with components of evidenced-based diabetes management such as education, 
self-management, support, and feedback loop. The implications of this project for 
positive social change include the integration of telehealth interventions in the outpatient 
setting to manage T2DM with enhanced access to care, reduction in health disparities, 
and improved health outcomes for society. 
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Section 1: Overview of the Doctor of Nursing Capstone Project 
Introduction 
While the use of telehealth in healthcare is becoming more prominent, it is not 
known if it can be used in the management of type 2 diabetes (T2DM). Diabetes has 
become a global public health problem. It is the seventh leading cause of death in the 
United States, playing a large contributory role in the long-term list of complications that 
remain costly to all healthcare systems (Gervera & Graves, 2015; Heron, 2018). Some of 
the potentially fatal complications of diabetes include but are not limited to 
cardiovascular diseases, kidney failure leading to dialysis, vision problems, and 
amputation of limbs (American Diabetes Association [ADA], 2018a; Burchard & 
Sadarangani, 2014). Keeping blood glucose levels as close to normal limits as possible 
remains the main aim of diabetes management in order to improve symptoms and 
minimize complications (Lee, Greenfield, & Pappas, 2018). To achieve this aim, close 
monitoring of blood glucose and a working relationship between patients and their 
healthcare providers are very crucial. This means that the conventional face-to-face 
outpatient care is not sufficient in meeting this aim, and this is where telehealth can be 
useful in improving diabetes management (Lee et al., 2018). Reducing the burden of 
diabetes and improving quality of life for patients with diabetes and those at risk of 
becoming diabetic remains a goal of Healthy People 2020 (2018). 
The use of information technology is becoming more dominant in the 
management of chronic diseases including diabetes, allowing consumers to receive 
healthcare services from the comfort of their homes. This is particularly true in telehealth, 
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which is defined as the exchange of information from one site to another via electronic 
communication to improve patient health outcomes (Tuckson, Edmunds & Hodgkins, 
2017). There is the need for the inclusion of alternative methods, such as telehealth, in the 
management of patients with T2DM given the potential long-term complications and 
rising health care costs (Burchard & Sadarangani, 2014). 
Telehealth is described as having the potential to not only improve the quality of 
care but also the accessibility, uses, and effectiveness of healthcare (Van Dyk, 2014). 
Despite this fact, the adoption of telehealth remains slow and many factors such as 
resistance to change are contributory barriers to adopting telehealth by healthcare 
providers (Kruse et al, 2016). The aim of this DNP capstone project was to perform a 
systematic literature review evaluating telehealth interventions in the management of 
patients with T2DM in the outpatient setting with resultant improvement in glycemic 
control (HgA1c).  
The nature of this DNP capstone project was to conduct a systematic literature 
review by extracting data from various evidence-based sources, seeking to find sources 
using telehealth in the management of T2DM and their findings. This capstone project 
correlates with DNP Essentials I and IV, which are scientific underpinnings for practice 
and information systems/technology and patient care technology for the improvement and 
transformation of health care (American Association of Colleges of Nursing [AACN], 
2006). This DNP capstone project holds the potential for positive social change because it 
presented the state of evidence on the effectiveness of telehealth in the management of 
T2DM. 
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Problem Statement 
Despite advances over the years in diagnosing, treating and preventing the 
progression of T2DM, it remains prevalent, with many T2DM patients still not reaching 
optimal glycemic levels (ADA, 2018a). In recent years, telehealth has emerged as a 
delivery method for providing oversight of patients diagnosed with diabetes and other 
chronic illnesses. At the DNP student’s site of employment where a remote monitoring 
telehealth program is practiced, resistance to change by the primary care providers can be 
attributed to the slow adoption of the program in T2DM management. Traditionally, 
management of T2DM patients is done via face-to-face visits, which can be resource 
intensive, costly, and very time consuming for both providers and patients (Burchard & 
Sadarangani, 2014). To date, there is evidence that the integration of telehealth in the 
management of diabetic patients can assist with improving health outcomes (Steventon, 
Bardsley, Doll, Tuckey, & Newman, 2014). This raises the question of which telehealth 
interventions have been shown to be effective in the care management of the diabetic 
patient. Using a systematic literature review approach, the focus of this DNP capstone 
project was the identification and evaluation of telehealth interventions that have been 
shown to be effective in lowering the glycemic levels in T2DM. 
Purpose Statement 
There are many documented barriers to the adoption of telehealth by healthcare 
providers of which resistance to change is one, even with evidence of telehealth’s 
promise to increase access and efficiency of care (Burchard & Sadarangani, 2014). Cund 
(2018) argued that even though providers are using technology in the care of patients, 
4 
 
they are not using technology to its full potential. A recent report estimated the total 
economic burden of diagnosed diabetes at $327 billion in 2017, which is a 26% increase 
from $245 billion in 2012 (ADA, 2018b). To combat this public health challenge, a 
multifaceted approach (not just the traditional health care approach) is needed including 
the use of telecommunication modalities (Lee et al, 2017). Hence, the purpose of this 
DNP project was to examine and evaluate modalities used by telehealth providers to 
lower glycemic levels and thus improve patient outcomes in those diagnosed with T2DM.   
Practice-Focused Questions  
Using a systematic literature review approach, the practice-focused questions 
guiding this DNP project were: 
PFQ1: What evidence-based modalities used by telehealth providers have 
emerged in the literature from 2013 to 2018 for lowering glycemic levels in adult 
clients diagnosed with T2DM? 
PFQ2: Using an evidence hierarchy system, how do these evidence-based 
telehealth modalities rate in terms of effectiveness? 
Nature of the Doctoral Project 
Literature suggests the potential of telehealth in realizing the quadruple aims of 
health care, which include improved patient experience, improved population health, 
reduced cost, and improved care experience (Tuckson et al., 2017). To answer the 
practice-focused questions, I completed an exhaustive and comprehensive search of 
databases such as CINAHL, Medline, PubMed, and Embase for relevant literature using 
key search terms. This systematic review entailed the review of literature from multiple 
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sources of evidence. Examples of evidence include randomized controlled trials (RCTs) 
and case, quasi-experimental, and other studies. 
I utilized key search terms such as telehealth, hgA1c, and type 2 diabetes mellitus 
to locate relevant evidence-based sources. The search was focused on sources written 
between 2013 and 2018 in order to be informed of more recent evidence-based sources 
on the phenomenon of interest. Inclusion criteria were original studies with participants 
18 years of age and older diagnosed with type 2 diabetes, studies comparing standard or 
usual care (outpatient) to telehealth interventions, and reported outcomes on glycated 
hemoglobin levels. Sources were excluded if they were not written in English, 
participants were less than 18 years of age, participants had type 1 diabetes, or if there 
were no reported outcomes on glycated hemoglobin. I appraised studies for quality of 
data extracted, and I analyzed, synthesized, and interpreted results for applicability. 
Significance 
The stakeholders for this capstone project include the patients diagnosed with 
T2DM, their families, and the health care professionals around the globe providing care 
for such patients. For the patients with T2DM, this project presented telehealth 
interventions available to assist them with increasing and mastering self-management 
skills and providing easy access to their health care providers. For healthcare providers, 
this capstone project served as a presentation of the current state of evidence to assist 
them in applying nontraditional approaches in the management and support of patients 
diagnosed withT2DM. This DNP capstone project contributed to the body of evidence-
based resources for the care of adults with T2DM. Hence, there is the potential of 
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transferability of this doctoral project to reviewing the impact of telehealth to other 
chronic disease conditions and mental health problems. 
This doctoral project has implications for the nursing profession and for positive 
social change because diabetes remains a global issue. In the United States alone, 
attributable medical expenditure for diabetes increased from $116 billion in 2007 to $176 
billion in 2012 (Olson et al, 2015). As health information technology advances, telehealth 
can possibly be a means of managing chronic conditions such as diabetes. Increased 
access to care via telehealth modalities can reduce disparities and improve care locally, 
nationally, and internationally. Harnessing the potential of technology can provide better 
access to information in patients with chronic disease, thereby improving self-
management skills (Salisbury et al., 2015). Thus, exploring all possible options in the 
control of diabetes is imperative in reducing the increasing morbidity and mortality rates 
associated with diabetes. 
Summary 
This section introduced the topic of the DNP capstone project, which is to present 
the state of evidence regarding the effectiveness of telehealth interventions in the 
management of T2DM. This section provided an overview of the nature of the DNP 
project including problem statement, purpose, practice-focused questions, and the social 
change implications of the project. In Section 2 I explore the model/framework for the 
DNP project, relevance of the DNP project to nursing practice, local background and 
context, and my role as the DNP student. 
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Section 2: Background and Context 
Introduction 
T2DM affects millions of people worldwide and comes with significant personal 
and social implications, which include increases in mortality and morbidity rates 
(Bagnasco et al, 2014). The use of technology has been deemed promising in offsetting 
some of the challenges healthcare providers face in providing self-management care and 
support to patients with chronic diseases including diabetes (Nundy et al, 2014). Despite 
strides in health information technology, healthcare providers are not utilizing it to its full 
potential. This is particularly true in telehealth, which has the potential to increase 
accessibility and quality of care provided beyond the traditional face-to-face 
appointments between patients and healthcare providers. I focused this DNP capstone 
project on performing a systematic literature review to present the current state of 
evidence on the effectiveness of telehealth in the reduction of glycemic levels in T2DM 
patients. In this section I discuss the concepts and models that served as frameworks for 
this DNP project. Also included are the relevance of the problem to the nursing 
profession, local background and context, and my role as the DNP student. 
Concepts, Models and Theories 
Joanna Briggs Institute’s Systematic Review Process  
The Joanna Briggs Institute’s (JBI) systematic review process approach served as 
the framework for this DNP systematic review project. JBI describes the systematic 
review and synthesis of evidence as the core of evidence-based practice (Peters et al. 
2015). It is also viewed as the analysis of available literature in order to determine how 
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effective or ineffective a given practice is. It comprises of the following stages: 
developing a rigorous proposal, stating the question(s), identifying inclusion criteria, 
detailing strategies to use in identifying relevant literature, assessing quality of the 
literature, extraction of data and finally synthesis and summary of the literature (Godfrey 
& Harrison, 2015; JBI, 2018; Peters et al. 2015). JBI concerns itself with the 
appropriateness, meaningfulness, feasibility and delivery of healthcare practices and as 
such view results of well-designed research studies of any methodology as potential 
sources of credible evidence, not just RCTs (Peter et al. 2015). Below is further 
expansion on the stages of the JBI’s systematic review process: 
• Develop review proposal: This serves as a guideline and assists with 
maintaining focus on the topic throughout the review process. This stage 
briefly included research questions, inclusion/exclusion criteria, and databases 
to search, assessing quality of studies, data extraction methodology, and the 
strategies for synthesis of data. 
• Develop review question(s): This stage encourages the use of PICO in 
formulating the question in order to provide clarity regarding the review 
focus, guidance in the literature search, and data extraction. 
• Identify inclusion and exclusion criteria: The PICO process assists with 
determining inclusion and exclusion criteria. The inclusion criteria in this case 
addressed participants, interventions, outcomes, and research methodologies 
considered such as RCTs, case studies, and many others. 
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• Search strategy: The search process detailed the keywords, initial search, 
subsequent search, selecting studies, and maintaining a record of searches. 
Use of a decision tree tool such as the PRISMA remains crucial. 
• Critical appraisal: This phase is aimed at limiting biases and establishing the 
validity of the article. 
• Data extraction: This phase involves the summarization of pertinent 
information from each study, which includes methods, interventions, and 
outcomes. 
• Data synthesis: This involves capturing the essence of the phenomenon of 
interest and following the three steps: identifying findings, grouping them into 
categories, and grouping categories into synthesized findings. 
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Chronic Care Model 
 
Figure 1. The chronic care model. Used with permission from ACP-ASIM Journals and 
Books (see Appendix F). Source: Wagner, E. H. (1998). Chronic disease management: 
What will it take to improve care for chronic illness? Effective Clinical Practice, 1(1), 2-
4. 
The chronic care model is a call for changes in the healthcare system that are 
based on evidence in order to meet the care needs of patients with a chronic disease. 
Wagner (1998) purported that management of chronic illnesses should not be the sole 
effort of the primary provider but rather that of an integrated and sometimes expanded 
team. The model is composed of six components that have the potential to affect 
outcomes in disease management (Baptista et al. 2016; Stellefson, Dipnarine, & Stopka, 
2013). These authors purported that the components serve to create a more effective 
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health care delivery system that will make available comprehensive self-management 
support services for patients with chronic disease such as diabetes using all available 
resources (Stellefson et al., 2013). These components include: 
• the organization of health care, which is making available resources and 
minimizing barriers to access to care; 
• self-management support, which is teaching patients self-management skills 
and empowering them; 
• decision support, which is providing necessary guidance for evidence-based 
care implementation; 
• delivery system design, which is coordinating care processes; 
• clinical information systems, which are tracking progress and reporting 
outcomes; and 
• community resources and policies, which involve using community-based 
resources to sustain care. 
Organization of health care details the importance of support from healthcare 
organizational leaders. Their support facilitates strategic changes that will promote a 
culture of high-quality care, effectively manage quality control issues, reduce barriers to 
access to care, and facilitate communication (Baptista et al. 2016; Stellefson et al., 2013). 
With self-management support, interventions are provided and examined to evaluate the 
client’s recognition of their role in their health care and their ability to assume self-
responsibility. To be effective, the patient and the health care provider identify the 
problem, set priorities and goals, develop care plans, and then monitor effectiveness of 
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self-care (Baptista et al. 2016). Introducing scientifically based clinical guidelines to 
decision support systems promotes attention to daily healthcare practice. The clinical 
decision support systems should include alerts, reminders, and feedback to be effective 
(Baptista et al. 2016). The delivery system design requires that health care needs, roles, 
and tasks be defined so that care can be structured and provided by a multidisciplinary 
team. The delivery system design also implies that new forms of provision of care that 
are beyond the face-to-face visits need to be implemented in order to sustain attention 
from a distance (Baptista et al. 2016). Clinical information systems should be efficient 
and effective, with alerts, reminders, and feedback for users. It should also summarize 
clinical information enabling identification of at-risk groups and monitor system 
performance and quality of service. Finally, the community resources and policies 
component should aim at using community resources and partnerships to improve health 
care (Baptista et al. 2016). 
This model fits perfectly because telehealth in the context of this project is 
considered to have the potential to positively impact the management of chronic diseases 
such as T2DM. Applying the chronic care model is feasible in the sense that the support 
of organizational leaders in providing the necessary resources to implement, maintain and 
reduce possible barriers lead to high adoption and use of programs. Most remote 
monitoring telehealth programs have the solid foundation of the provision of self-
management education and support for the patients enrolled in the program. The systems 
are also equipped with clinical decision support with alerts, reminders, and feedback 
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mechanisms. With telehealth, there are identified healthcare professionals with defined 
roles within a multidisciplinary team to promote and maintain the health of participants. 
The TElehealth in CHronic Disease Model 
 
Figure 2. The TElehealth in CHronic disease (TECH) model for telehealth to support 
patients with chronic conditions. Used with permission from BMJ Open (Appendix G). 
Source: Salisbury et al. (2015). TElehealth in CHronic disease: Mixed-methods study to 
develop the TECH conceptual model for intervention design and evaluation. BMJ Open, 
5(2). e006448. 
 
The TElehealth in CHronic disease (TECH) model was developed with the 
premise that as the population ages, there will be increasing number of people with 
chronic diseases. Their needs will pose the risk of overwhelming the ability to provide 
the conventional scheduled face-to-face appointments between patients and their 
providers (Salisbury et al., 2015). The authors also indicated that they developed this 
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conceptual model because telehealth is a complex intervention requiring interacting 
components, such as the technology, infrastructure, available human support, and patient 
capabilities. This model contains four components with key outcomes including 
improved access, health, patient experience, and cost. The components include: 
• engaging patients and health professionals; 
• including subcomponents of self-management, treatment optimization, and 
care coordination for effective management of chronic diseases; 
• effective partnership between providers; and 
• patient, social, and health system context. 
Engaging patients and health care providers are very important in the success of 
any telehealth program. The authors noted low enthusiasm and sometimes resistance or 
hesitance towards adoption of telehealth interventions by healthcare providers (Salisbury 
et al., 2015). Engaging health care professionals with evidence of telehealth 
interventions, eliminating concerns for duplication of care, employing technology that is 
user friendly, clearly defining roles of traditional and telehealth providers, and 
maintaining good communication between providers will greatly influence their 
participation (Salisbury et al., 2015).  
Relevance to Nursing Practice 
Diabetes has become a growing global issue due to increasing morbidity and 
mortality rates (ADA, 2017). As the number of people with diabetes continues to grow 
despite increases in traditional care, so does the urgency to find alternative methods that 
can supplement conventional care for this chronic disease. The use of information 
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technology in providing healthcare is becoming very prevalent but there is ongoing 
evidence of barriers to adopting them or using them to its full extent. Amongst the 
barriers is the reluctance to change by healthcare providers. This barrier could be as a 
result of caseloads and time pressures causing providers not to automatically think of 
using available technology (Taylor & Coates, 2015).  
Telehealth solutions have the potential to increase self-management and 
empowerment in patients, improve communication between patients and their healthcare 
providers including nurses, and enhance patient-centered care (Koivunen & Saranto, 
2018). The increasing focus on outpatient care instead of inpatient care and decreasing 
rates of hospital length of stay is creating the need to adopt new tools such as telehealth 
in nursing practice (Koivunen & Saranto, 2018). The Institute of Medicine’s report titled 
The Future in Nursing, Leading Change, Advancing Health, recommended that nurses 
expand their roles in health care and master the use of information technology systems to 
improve inter-professional relationships and coordination of care (IOM, 2011). This 
doctoral project advances nursing practice by presenting the state of evidence after 
conducting an exhaustive systematic literature review on the lowering of glycemic levels 
in T2DM patients using telehealth. 
Type 2 Diabetes Mellitus 
Diabetes is a health condition where the blood glucose is higher than normal 
values, caused by insulin deficiency, and is usually diagnosed when hgA1c is equal to or 
greater than 6.5% (ADA, 2018a, 2018b, 2018c). The Center for Disease Control and 
Prevention in 2016 estimated that 1 in every 11 people have diabetes which comes out to 
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be approximately 29.1 million people (CDC, 2016). The financial burden of diabetes 
cannot be overlooked; the ADA in 2017 published a report titled the economic cost of 
diabetes in the U.S. This report detailed the increased financial burden of care and health 
resources (ADA, 2018a).  
There are other types of diabetes but Type 2 is the most prevalent with diagnosis 
including testing of fasting blood glucose, hgA1c and 2-hour postprandial glucose during 
a 75gm oral glucose tolerance test (ADA, 2018c). For most patients with T2DM, a 
reasonable hgA1c goal is less than 7.0%. Reports have shown though that most T2DM 
patients are not reaching this goal, in fact about only 50% of patients in the U.S. 
diagnosed with this condition are reaching the goal of hgA1c less than 7.0% (ADA, 
2018a). 
T2DM as previously stated is associated with increased morbidity and mortality. 
Some of the associated complications include vision problems (including blindness), 
neurological disorders, cardiovascular disorders, non-healing wounds leading to 
amputations, kidney disease leading to dialysis, and many others. The treatment or 
management of T2DM involves the use of glucose lowering medications and lifestyle 
modification. The goal of management is to teach self-management skills, which include 
self-monitoring of blood glucose (SMBG), and provide support to assist in maintaining 
self-management skills. The use of diabetes self-management education and support has 
proven to be evidence-based in the management of diabetes and can help with improving 
outcomes (ADA, 2018c). 
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Telehealth 
Telehealth is described as the delivery of healthcare services from a distance 
using information and telecommunication technologies to exchange valid information for 
diagnosis, treatment, health-related education and the advancement of public health 
(Health Resource and Service Administration, 2015; World Health Organization, 1998). 
Telehealth can be used to provide remote patient monitoring and provide education in the 
management of chronic disease processes. Telehealth has also been described as being 
associated with reduced hospital admissions and emergency department (ED) visits, 
reduced length of hospital stays and overall reduction in mortality rates (AHRQ, 2016; 
Xiang, Li, & Liu, 2013). Nursing care is increasingly being delivered at home than in 
institutions and telehealth makes it possible for patients to remain in their home while 
receiving quality care for chronic disease and communicate effectively over a distance 
with their health care providers (Koivunen & Saranto, 2018). Telehealth services or 
interventions can be deployed via telephones including mobile phones, computerized 
internet-based devices, remote monitoring devices such as automated self-monitoring 
devices, telemeasuring devices, video cameras and wireless Bluetooth devices 
(Kalankesh, Pourasghar, Nicholson, Ahmadi, & Hosseini, 2016). 
In the management of T2DM, the Agency for Healthcare Research and Quality 
(2016) described telehealth as validating the improvement of adherence to diabetes self-
management. Coughlin (2017) purported that the introduction of telehealth in the 
management of T2DM is very crucial due to the potential for improving clinical 
outcomes, care coordination and patient satisfaction. This is because telehealth makes 
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provision for patients to communicate with their healthcare providers regarding their 
glycemic control and for providers to monitor glucose levels and provide feedback in 
real-time. This feedback loop allows for the provision of self-management skills 
education, modification of treatment and monitoring of outcomes (Coughlin, 2017). 
The Veteran Health Administration (VHA) adopted the use of telehealth 
interventions in the management of veterans with chronic diseases such as diabetes. The 
VHA’s home telehealth has the basis of the chronic care model, connecting disease 
management to home. This model of care in the VA is referred to as care coordination 
home telehealth (CCHT). The CCHT program in the VA is considered successful in 
managing T2DM due to the provision of ongoing assessment, monitoring, and case 
management of veterans from their home providing “just in time” care (Gervera & 
Graves, 2015). Diabetic veterans enrolled in the program transmit biometric data (blood 
glucose, blood pressures and weights) via a home monitoring device, in addition to 
responses to assessment questions. The data, transferred through a secure portal are 
reviewed by an RN care coordinator, who interprets data, provide interventions as needed 
and documents in the electronic health record for other clinicians to view (Gervera & 
Graves, 2015). The current data on the increasing number of adults 18 years and older 
diagnosed with T2DM require the exploration of other management methods such as 
telehealth in addition to the conventional face-to-face meetings with health care 
providers. 
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Context and Role of the Doctor of Nursing Practice Student 
This DNP project served as a systematic literature review and as such was not 
bound by a setting. Inclusion and exclusion criteria for selecting evidence-based literature 
were used in place of designating a setting. The inclusion criteria as shown below in 
Table include literature written between 2013 and 2018, studies of adults 18 years and 
older diagnosed with T2DM, and the use of telehealth interventions in managing T2DM 
with resultant effect on the hemoglobin A1c. Exclusion criteria include literature not 
written in English, systematic reviews, studies with children younger than 18 and patients 
with type 1 DM. The level of evidence of the selected literature was categorized 
accordingly using the level of evidence for effectiveness by the JBI (2014).  
Table 1 
 Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
Articles published between 2013 to 2018 Participants less than 18 years old 
Focus on original study, not review of 
many studies 
Systematic reviews 
Participants 18 years and above HgA1c not being the principle outcome 
measure 
Participants are diagnosed with T2DM Non-English article 
Article written in English Specificity is not to T2DM 
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HgA1c is the principle or one of the 
principle outcome measures 
Not comparing telehealth to usual care in 
outpatient setting 
Full text articles Focus on EHR and not on telehealth 
technology 
 Abstract only articles 
 
I am a master’s prepared registered nurse with over twenty-two years of varied 
experience in the profession. I have had the opportunity to use telehealth interventions in 
providing care to patients with chronic diseases such as T2DM. In this service, I observed 
that healthcare providers (physicians, RNs and pharmacist) are not utilizing this service 
to its full potential for varied reasons including resistance to change. I saw this lack of 
use as an opportunity to seek improvement in the management of T2DM patient 
population using technology. I served as the leader of this DNP capstone project and 
completed a systematic review in order to present the current state of evidence regarding 
telehealth and T2DM management and also to answer the practice focus questions. 
Definition of Terms 
Prisma: Preferred reporting items for systematic reviews and meta-analyses 
(Moher et al. 2009). 
Hemoglobin A1c (HgA1c): An indirect measure of average blood glucose levels 
(ADA, 2018c).  
Self-management skills: This the development of a generic set of skills that has 
proven successful in allowing individuals to effectively manage their chronic illness and 
improve health outcomes (Grady & Gough, 2014). 
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Care coordination: The deliberate organization of patient care activities and 
sharing of information among all of the participants concerned to achieve safer and more 
effective care (AHRQ, 2018). 
Self-monitoring blood glucose (SMBG): Self-monitoring of blood glucose levels 
by patients to evaluate their individual response to therapy and assess whether glycemic 
targets are being achieved (ADA, 2018c). 
Certified diabetes educator: Certified health care professional who applies in-
depth knowledge of diabetes and skills to enable diabetic patients to manage daily and 
future challenges (Burke, Sherr, & Lipman, 2014). 
Diabetes self-management education/support (DSME/S): Collaborative process to 
educate diabetic patients, helping them to gain knowledge and skills necessary to self-
manage the disease process and its related conditions (Burke, Sherr, & Lipman (2014). 
Summary 
This chapter discussed models that informed this DNP capstone project (the 
chronic care model and the TECH model) including the use of the JBI for systematic 
review as the framework. Also discussed was the background of T2DM and Telehealth, 
and various terms used in the understanding of the project itself. Relevance to nursing 
practice, context and the role of the DNP student were also discussed. The next chapter 
will discuss the sources of evidence, collecting and analyzing sources of evidence. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
Telehealth interventions have the potential to improve outcomes in the 
management of chronic diseases, but despite this potential, there are still barriers in 
adopting its use. My aim in this DNP capstone project was completing a systematic 
literature review presenting the current state of evidence regarding the use of telehealth 
interventions in the management of T2DM. For this DNP capstone project, I used the JBI 
systematic review process as a framework. This chapter presents the sources of evidence 
used, the tools for collection, and the analysis and synthesis of data. 
Practice-Focused Questions 
Diabetes is a global health concern and the aim of management remains to keep 
blood glucose as close to normal as possible, improve symptoms, and minimize long term 
complications (Lee et al., 2018). The urgency for improvement of diabetes management 
means that the conventional outpatient care is no longer sufficient. A growing body of 
evidence supports the use of innovative technologies such as telehealth in the monitoring 
and management of patients with diabetes over a distance and as frequently as necessary 
(Burchard & Sadarangani, 2014; Lee et al., 2018). Despite this growing body of 
evidence, telehealth technologies are not being used by healthcare providers to their full 
potential in the management of T2DM (ADA, 2018a). Using a systematic literature 
review approach, the practice-focus questions that guided this evidence-based DNP 
project were: 
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PFQ1: What evidence-based modalities used by telehealth providers have 
emerged in the literature from 2013 to 2018 for lowering glycemic levels in adult 
clients diagnosed with T2DM? 
PFQ2: Using an evidence hierarchy system, how do these evidence-based 
telehealth modalities rate in terms of effectiveness? 
Sources of Evidence 
The sources of evidence came from the exhaustive searches of prominent 
electronic databases for peer-reviewed literature in an attempt to answer the practice-
focused questions. The focus of the search was to identify literature with the strongest 
evidence, and that included RCTs, case studies, and quantitative studies. I evaluated the 
level of evidence of the selected literature using the JBI’s (2014) levels of evidence for 
effectiveness and were categorized accordingly.  
Relationship of Evidence to Purpose 
My goal for this capstone project was to present the state of evidence on the use 
of telehealth interventions in the management of T2DM with resultant improvement in 
hgA1c. With the increasing number of adults diagnosed with T2DM, there is the need to 
employ other methods of management that is beyond the traditional face-to-face provider 
visits. Key search terms as identified below were used to identify as much literature as 
possible that focused on the use of telehealth in the management of T2DM. 
Collection and Analysis of Evidence 
As stated in the inclusion criteria, I collected literature written between 2013 and 
2018 to make sure that the most current evidence was reviewed. I reviewed titles and 
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abstracts and included articles if they had relevant information regarding the phenomenon 
of interest and could assist in answering the practice-focused questions. The goal was to 
collect and analyze studies that can assist in presenting the current state of evidence in the 
use of telehealth to manage T2DM and subsequently reducing the glycated hemoglobin. 
Published Outcomes and Research  
To complete this DNP capstone project, I conducted an exhaustive and 
comprehensive literature search using databases such as Cumulative Index of Nursing 
and Allied Health Literature (CINAHL), MEDLINE, PubMed, ProQuest and Embase. 
Key search terms used include telehealth, type 2 diabetes, and hemoglobin A1c. I used 
Boolean operators (and, or and not) to identify relationships between the search terms and 
narrow the search results. I used a matrix table (see Appendix I) to summarize results 
from the sources. The search focused on literature written between 2013 and 2018 in 
order to provide the most recent schools of thought on the phenomenon of interest. I 
applied inclusion and exclusion criteria in the selection of literature.  
Protections  
This DNP capstone project is a systematic literature review. No collection of data 
from human subjects occurred. However, I followed the steps in the systematic literature 
review manual in seeking the approval of the Walden University’s Institutional Review 
Board for the completion of this project (Walden Institutional Review Board approval no. 
01-10-19-0290222).  
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Analysis and Synthesis 
I selected and reviewed literature meeting the inclusion criteria. Organization is 
very crucial throughout a literature search process (Holly, Salmond & Saimbart, 2017). I 
used a search log to track search strategies, as well as a decision tree (PRISMA tool). I 
used a literature matrix (Appendix I) to record and organize evidence. The involvement 
of another independent investigator was necessary to assist with the review of titles and 
abstracts. All literature meeting the inclusion criteria were subject to JBI’s level of 
evidence for effectiveness in order to rate the evidence and establish validity of the 
literature. I grouped findings into categories and categories into synthesized findings. 
Categories in this case were groups of findings that had similar relationships among 
variables or circumstances and informed the practice (Godfrey & Harrison, 2015). 
Summary 
The DNP capstone proposal discussed diabetes becoming a global health issue 
and due to the advancement in health technologies, telehealth interventions present 
opportunities for improved management of diabetes (So & Chung, 2017). Despite the 
growing evidence of telehealth’s potential, it is not being used to its full potential. I also 
discussed the practice-focused questions that guided this DNP capstone project. I 
reviewed the sources of literature evidence, inclusion and exclusion criteria, and methods 
of data organization, analysis, and synthesis. In the next chapter, I discuss the findings of 
the systematic literature review, as well as recommendations, strengths, and limitations of 
the project. 
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Section 4: Findings and Recommendations 
Introduction 
Telehealth has been described as having the potential to improve the quality, 
accessibility, utilization, and effectiveness of care (Van Dyk, 2014). The question is what 
role it can play in managing T2DM, which is now a complicated, multifaceted and global 
chronic disease process. Keeping glycemic levels as close to normal as possible for 
T2DM patients is crucial in their management in order to improve symptoms and 
minimize complications. Identifying outpatient interventions that have been proven to 
improve health outcomes in T2DM patients such as lowering hgA1c is imperative. The 
conceptual models for this DNP project were the chronic care model and the TECH 
model; I discussed both in detail in Chapter 2. This DNP capstone project was guided by 
the following questions:  
PFQ1: What evidence-based modalities used by telehealth providers have 
emerged in the literature from 2013 to 2018 for lowering glycemic levels in 
T2DM? 
PFQ2: Using an evidence hierarchy system, how do these evidence-based 
telehealth modalities rate in effectiveness? 
To answer the practice-focused questions, I performed a systematic literature 
review to appraise current evidence to determine the use and effectiveness of telehealth in 
the management of T2DM in the outpatient setting. The search for evidence included 
scholarly publications from 2013 to 2018 including articles from CINAHL, Medline, 
PubMed, ProQuest and Embase. I used a PRISMA flow chart diagram (Appendix A) as a 
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decision tool to review abstracts and full-text articles and to exclude articles that did not 
meet study criteria (see Table 1). Articles meeting the inclusion criteria were selected, 
analyzed and critically appraised using the JBI (2018) data extraction form (Appendix B) 
and critical appraisal forms (Appendices C, D, & E), then grouped into categories of 
interventions. To achieve rigor and validity, a second reviewer (doctoral prepared) was 
invited to participate in article selection and data extraction. Eighteen articles met criteria 
for this doctoral capstone project, and in this chapter, I discuss the findings, implications 
for nursing practice/social change, recommendations, strength, and limitations of the 
project.  
Findings and Implications 
Eighteen articles met the inclusion criteria, fifteen articles were RCTs, one study 
was quasi-experimental, one an exploratory study, and one was a case study. The quality 
of evidence for grading these studies was based on the JBI’s Level of Evidence for 
Effectiveness (2018). A review of selected articles noted the application of several 
telehealth interventions or modalities in the management of T2DM, including telephone, 
Internet, remote telemonitoring equipment, clinical video telehealth (CVT), and smart 
phones/apps. Some studies applied a single telehealth intervention, while some used 
multiple telehealth interventions at the same time. I discuss each in detail below. It’s also 
important to point out that in all the included studies, hgA1c was either the primary 
outcome measure or one of the primary outcome measures. Overall, most of the evidence 
indicates effectiveness in using telehealth in the management of T2DM with a resultant 
decrease in the hemoglobin A1c. 
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Telehealth Interventions/Modalities 
Telephone interventions. Telephone intervention is defined as an intervention 
that makes it possible for a healthcare professional to verbally communicate remotely 
with patient or caregiver (Corry, Smith, Neenan, & Brabyn, 2017). Telephonic 
intervention is considered the most basic form of telehealth intervention, where the 
healthcare provider assumes the role of the facilitator, helping the patient on the other end 
to determine what is more important for them to address health wise (Niemczewski, 
Polivka, Clark, 2016). In my review, four studies discussed the use of telephonic 
intervention in the management of T2DM in the outpatient setting as a single modality 
(Niemczewski et al., 2016; Odnoletkova et al., 2016), with two of them combining the 
use of another telehealth modality (Crowley et al., 2016; Nicolucci, Cercone, Chiriatti, 
Muscas, & Gensini, 2015). The telephonic interventions in these studies all aimed at 
providing quality diabetes self-management education and coaching patients through 
self-determined or preset goals with resultant decrease in hgA1c. This telephone 
interaction between the healthcare providers who are primarily nurses and the patient 
enhance communication, providing a means of assessing patients’ ability to manage their 
own care at home with resources provided. The participants in the telephone intervention 
from both studies (n= 303) achieved a reduction in their hgA1c (7.9% to 6.8%) at the end 
of the study (Niemczewski et al., 2016; Odnoletkova et al., 2016). 
Crowley et al. (2016) and Nicolucci et al. (2015) used telephone interventions in 
combination with remote monitoring intervention. The remote monitoring allows for 
transmission of vitals including blood sugar regularly, followed by telephone calls, which 
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are either scheduled or unscheduled due to high stratification of data transmitted. These 
researchers determined that scheduled phone calls where structured or comprehensive 
diabetes education is provided help patients with staying on track with their goals, 
empowering them to gain independence in self-management. Unscheduled phone calls 
assist the patient to determine the cause of the abnormal reading or response and set goals 
or activities to minimize the frequency of abnormal readings. Results in both studies 
showed significant reductions in hgA1c in the intervention groups. These studies 
concluded that telehealth is effective in managing T2DM patients in the outpatient 
setting, and any improvement in hgA1c by 1.0% can reduce microvascular complications 
by 37% (Crowley et al., 2016). 
Internet interventions. Internet-based interventions are described as treatments 
that are delivered through an Internet connection with some therapeutic tasks done 
through the computer (Andersson & Titoy, 2014). The majority of the studies reviewed 
used this telehealth intervention method to manage T2DM in the outpatient setting 
(Istepanian et al., 2014; Kempf et al., 2017; Kim et al., 2016; Lim et al., 2014; Tang et 
al., 2013; Wang et al., 2017; Zhou et al., 2014). The Internet is a worldwide 
communication tool. These researchers found that the use of this methodology, which 
included Internet-based blood glucose monitoring systems, allowed for automatic upload 
of vital signs and other data as required by the program via an Internet connection. The 
feedback loop allows for communication via Internet between the patients and the 
healthcare providers. With this means, the patients had frequent interaction with the 
healthcare providers, receiving patient-specific diabetes education. Recommendations or 
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changes in medications, frequency of blood glucose testing, modification of lifestyle, and 
encouragement were also made based on the recent data. At the end of the studies, 
participants in the intervention groups saw and maintained significant decreases in 
hgA1c. The researchers concluded that the use of this methodology is effective because 
timely recommendations appeared to be more effective in managing T2DM in the 
outpatient setting compared to the face-to-face outpatient or traditional care. 
Smart phones/applications. This is the provision of healthcare services using 
wireless/mobile devices (Parker et al., 2018). The studies using this methodology 
evaluated the ease of use of smart phone applications to target reduction in hgA1c in the 
outpatient setting (Fortmann et al., 2017; Orsama et al., 2013). The application allowed 
for manual entry or automatic transmission of blood sugar readings. Using a decision 
support system, automatic feedback was generated depending on the readings and 
responses (Orsama et al., 2013). One of the studies investigated the use and effectiveness 
of this methodology in an underserved Hispanic population with poor blood glucose 
control (Fortmann et al., 2017). These researchers noted that in this day of technology 
where almost everyone has some form of smart phone, this methodology served to 
increase acessibility to care for this population. With the application on the phone, the 
patients were able to upload blood sugar readings and other vitals, complete health 
sessions, receive diabetes education that is evidenced-based, and receive and sent 
feedback in the form of text messages to their healthcare providers. Istepanian et al. 
(2014), in their case study of T2DM patients in postwar Iraq, combined this methodology 
with Internet modality. With an application on their smart phone, participants also 
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received a wireless glucometer that was paired with the phone. It allowed for daily 
transmission of readings to a remote server via Internet link. This modality allowed for 
monitoring of progress of the T2DM patients, added no restrictions to their day to day 
activites, and increased communication between patients and their healthcare providers. 
At the conclusion of these studies, the intervention groups all achieved significant 
decreases in their hgA1c. 
Remote monitoring. Remote patient monitoring is the use of technology to 
collect health data from patients in one location, such as the home, and transmitting the 
data electronically to healthcare providers in a different location for review and 
recommendation (Vegesna et al., 2017). A total of four studies used the remote 
monitoring telehealth intervention, two of the studies (already discussed above) 
combined its use with other telehealth modalities (Crowley et al., 2016; Nicolucci et al. 
2015). Two of the reviewed studies demonstrated the use and effectiveness of remote 
monitoring telehealth interventions in the management of T2DM to reduce hgA1c 
(Greenwood, Blozis, Young, Nesbitt, & Quinn, 2015; Warren, Carlisle, Mihala, & 
Scuffham, 2017). Remote monitoring equipment in the form of a tablet device or hub can 
be placed in the patient’s home; some may have bluetooth compatibility with peripherals 
such as glucometer, blood pressure device, scale, and so forth. Some had video capability 
as well and could provide video conferencing with patient and healthcare providers. Just 
like the rest of the modalities, it also allowed for automatic upload or transmission of the 
vitals including blood glucose and other data as required. Data received were reviewed by 
healthcare providers (RNs, pharmacists, and physicians), and evidence-based diabetic 
32 
 
education was provided via daily health sessions. The healthcare providers were available 
by phone, clinical video, or messages via the remote monitoring equipment for support. 
At the end of the studies, participants in the intervention groups achieved significant 
decrease in their hgA1c approximately 0.9% to 1.13% (Greenwood et al., 2015 & Warren 
et al., 2017), validating the effectiveness of this telehealth intervention. 
Clinical video telehealth. CVT is described as real-time two-way video 
interaction between a patient and a healthcare provider over a distance in setting such as a 
patient’s home and the outpatient clinic, clinic to clinic, or hospital to clinic (Abel et al., 
2018). Two of the included studies (Rasmussen, Lauszus, & Loekke, 2016; Threatt & 
Ward, 2017) examined the use of CVT in the management of T2DM in the oupatient 
setting with resultant decrease in hgA1c. Diabetes education was provided one-on-one 
via an online video connection between the healthcare providers and the patients. With 
each visit, blood glucose readings were reviewed, medication adjustments made if 
necessary, and self-care goals reviewed for progress or barriers. At the conclusion of the 
studies, the particpants in the intervention groups achieved significant reduction in their 
hgA1c compared to the usual care group (Rasmussen et al., 2016; Threatt & Ward, 2017). 
These studies concluded that even though patients can achieve lowering of their hgA1c, 
the use of telehealth interventions offers an easy and effective method for managing 
T2DM in the outpatient setting (Rasmussen et al., 2016). 
33 
 
Telehealth in Type 2 Diabetes Mellitus 
 
Figure 3: Telehealth interventions in the systematic literature review. 
 
Telehealth interventions are described as being effective in improving the 
management of chronic illnesses such as diabetes (Coughlin, 2017). This systematic 
review identified studies that addressed the use of multiple telehealth interventions in the 
management of T2DM in the outpatient setting. In answering the first project-focused 
question, this systematic review noted many evidence-based telehealth interventions used 
in the management of T2DM clients, which included telephonic interventions, Internet-
based interventions, remote monitoring, clinical video telehealth, and smart 
phone/applications. A few themes were noted in all the interventions including the 
provision of self-management education, monitoring of blood glucose levels, and, most 
importantly, a feedback loop. 
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Self-management remains the cornerstone of controlling T2DM, hence the 
provision of some form of Diabetes Self-Management Education (DSME) in all the 
studies reviewed (Kempf et al., 2017; Nicolucci et al., 2015; Niemczewski et al., 2016; 
Warren et al., 2017). Many studies reviewed, indicated that the provision of frequent 
education and support is crucial to achieving and maintaining glycemic control in T2DM 
patients. Telehealth interventions can be used to provide structured diabetes education 
and support to T2DM patients in the outpatient setting compared to frequent face-to-face 
outpatient visits. Another element that proved crucial to the success of the studies is the 
feedback loop. This feedback loop has been determined to maintain communication 
between clients and their telehealth providers, providing the support needed for 
successful management of T2DM (Cho et al., 2017; Greenwood et al., 2015; Lim et al., 
2015; Niemczewski et al., Orsama et al., 2013; 2016; Rasmussen et al., 2016; Wang et 
al., 2017). 
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Figure 4: Sample feedback loop in telehealth management of diabetes. Developed by B. 
Ikpeama.     
 
The second practice-focused question sought information on how telehealth 
interventions rank in effectiveness. This question was answered using the JBI level of 
evidence for effectiveness as seen in Table 3 below.  
Table 2 
Levels of Evidence for Effectiveness 
Levels of Evidence Number of Articles 
Level 1.a – Systematic review of RCTs  
Level1.b – Systematic review of RCTs and other study 
designs 
 
Level 1.c - RCT 15 
Level 1.d – Pseudo-RCTs  
Level 2.a – Systematic review of quasi-experimental 
studies 
 
Level 2.b – systematic review of quasi-experimental and 
other lower study designs 
 
Level 2.c – Quasi-experimental prospectively controlled 
study 
1 
Level 2.d – Pretest or historic/retrospective control group 
study 
 
Telehealth 
equipment/modalit
y of choice 
Provider 
response/action to 
client and biometric 
data 
Evidence-based 
diabetic education 
including self-
management 
Provider 
review of 
response and 
biometric data 
Biometrics 
and client 
response 
transmitted 
Client 
response to 
education 
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Level 3.a – Systematic review of comparable cohort studies  
Level 3.b systematic review of comparable cohort and 
other lower study designs 
 
Level 3.c – Cohort study with control group 1 
Level 3.d Case controlled study  
Level 3.e – Observational study without control group  
Level 4.a Systematic review of descriptive studies  
Level 4.b – Cross-sectional studies  
Level 4.c – Case series  
Level 4.d – Case study 1 
Level 5.a – Systematic review of expert opinion  
Level 5.b – Expert consensus  
Level 5.c – Bench research/single expert opinion  
 
Adapted with permission from: Joanna Briggs Institute (2013). New JBI levels of 
evidence and grades of recommendation working party 2013. Retrieved from 
http://joannabriggs.org/assets/docs/approach/JBI-Levels-of-evidence_2014.pdf 
 
JBI level of evidence, when asking a clinical question can provide information on 
the appropriate study design to search for, providing a ranking based on the available best 
evidence (JBI, 2014). The majority of the studies included in this systematic review used 
most of all the telehealth interventions with rankings higher up on the JBI’s level of 
evidence (level 1c). Therefore, this systematic review concludes that none of the 
interventions are more superior than the other. Hence, any of the telehealth interventions 
mentioned above can be effective in managing T2DM in the outpatient setting, but 
consideration must be given to the setting and population before making a choice. Table 
4 below lists advantages and possible disadvantages of the telehealth interventions 
discussed. 
Table 3 
Advantages and Disadvantages of Each Discussed Telehealth Intervention 
Telehealth Interventions Advantages Disadvantages 
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Telephone -Increased access to care,  
-can be used to address 
service underutilization,  
-less expensive,  
-decrease use of primary 
and emergency care,  
-increased patient 
satisfaction as a result of 
receiving care without 
over burdening health care 
providers. 
-Some patients may be less 
invested and treat as a 
social call (though can be 
mitigated by maintaining 
structure and regularity).  
-Patients may miss calls, 
difficulty providing care 
over the phone if patient in 
crisis  
-risk of privacy violation 
(can be mitigated by having 
patient answer calls in a 
secure room). 
Internet-Based -done from comfort of the 
home 
-automatic feedback using 
the CDSS 
-graphical representation 
of data can be viewed by 
both patient and health 
care provider 
-access to ‘just in time’ 
education regarding 
diabetes self-management 
-improved access to 
evidence-based care 
-cost effective compared 
to usual care 
-may receive help faster 
from healthcare provider 
before the development of 
crisis 
-Need to have internet 
connection at home 
-be able to navigate the 
internet 
-privacy and security issues 
as with evolving 
technology 
Clinical Video -Increases access to care 
-real time or live video 
conferencing between 
patient and healthcare 
provider 
-allows for assessment and 
strategizing of patient care 
without being in the same 
room 
-patient and caregiver must 
be capable of using 
provided or existing 
equipment to complete 
visits 
-privacy and security issues 
as with evolving 
technology 
Remote Monitoring -Transmit data in real time 
to healthcare providers 
- privacy and security 
issues as with evolving 
technology 
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-improves quality of life 
for chronically ill patient 
by allowing them to spend 
more time at home and 
still be followed by their 
healthcare providers 
-cost effective due to 
reducing frequent face-to-
face visits 
- deployment is sometimes 
based on extensive wireless 
telecommunications 
infrastructure which may 
not be available in rural 
areas 
Smart Phones/Applications - increases access to care 
- can be used anywhere 
and any time 
- reduces traveling or 
physical presence of 
patients in remote areas 
into urban areas for health 
care 
- can be used in 
underserved or 
underinsured population 
- factors related to the 
telecommunication industry 
such as sustainability of 
connections, service 
interruption of network 
service, energy 
consumption or efficiency 
of the device 
- threats to privacy and 
confidentiality 
 
Nursing Roles 
The Institute of Medicine recommended that nurses expand their roles in 
healthcare, incorporate and master the use of information technology to improve inter-
professional relationships and improve coordination of care (IOM, 2011). Nurses are 
quite often the frontline healthcare providers in the community, positioning them to 
support all aspects of telehealth in the continuum (Fathi, Modin & Scott, 2017). Nurses 
are in the forefront of providing DSME/S to T2DM patients, and can use telehealth 
equipment to coach and monitor progress of self-care. Telehealth interventions provide 
the perfect opportunities for nurses in collaboration with other disciplines, to provide care 
in the outpatient setting for T2DM patients to decrease health disparities and improve 
outcomes such as hgA1c.  
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Relationship to Models 
The telehealth interventions are in congruent with the components of the Chronic 
Care and TECH Models guiding this DNP project. The results of this literature review 
have shown the positive impact of telehealth interventions in the management of chronic 
diseases such as T2DM. The telehealth interventions all provided diabetes education, 
feedback, collaboration with patient and healthcare providers, including multidisciplinary 
teams. These and more components played major roles in improving health outcomes in 
T2DM participants in the studies reviewed. Below is Table 4 detailing telehealth 
interventions relationship to these models. 
Table 4  
Relationship of Models to Telehealth Interventions 
Chronic care model TECH model  Telehealth interventions 
Organizing healthcare – 
making resources 
available and minimizing 
barriers 
Effective partnership between 
providers; providers and 
patients 
Integration can help 
reduce the ever-increasing 
burden of primary care 
providers (Fortmann et al., 
2017) 
Self-management support 
– providing patients with 
education and 
empowerment 
Includes subcomponents of 
self-management and 
treatment optimization 
Able to provide 
personalized self-
management education 
(Kempf et al., 2017; Tang 
et al., 2013) 
Decision support – 
providing guidance for 
evidence-based practice 
 Most interventions have a 
decision support system 
that triggers certain 
feedback based on the 
uploaded data (Lim et al., 
2016) 
Delivery system design – 
coordinating care 
processes 
Engaging providers and 
patients; Care coordination for 
effective management 
Allows for real time 
feedback loop enhancing 
communication between 
patients and healthcare 
staff (Nicolucci et al., 
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2015); Orsama et al., 
2013) 
Clinical information 
systems – tracking 
progress and reporting 
outcomes 
 Most systems have the 
ability to track and report 
glycemic readings for 
outcomes (Greenwood et 
al., 2015) 
Community resources – 
using community-based 
resources to sustain care 
Takes into consideration 
patient, health system and 
social contexts 
Interventions can be 
chosen to match patient’s 
skills and ease of use. Can 
also be used to address 
some health disparities 
(Crowlet et al., 2016; Kim 
et al., 201; Threatt & 
Ward, 2017; Istapanian et 
al., 2014) 
 
Implications for Practice 
This systematic literature review served to provide evidence of the effectiveness 
of telehealth in managing T2DM in the outpatient setting. At the community and 
institution levels, the implication of this project is such that adding to the knowledge base 
of healthcare providers regarding use of telehealth in T2DM management will assist them 
in effectively managing their patients with T2DM. When healthcare providers or health 
systems implement these evidence-based telehealth interventions in the management of 
T2DM patients, it increases access to care, engages patients to participate and learn self-
management skills, thereby improving their health outcomes. Reports indicate that only 
50% of patients with T2DM patients are reaching the goal of hgA1c less than 7.0% 
(ADA, 2018c). Implementing and using telehealth interventions can improve these 
numbers and improve health outcomes for patients with T2DM. 
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Implications for Social Change 
Implications of this systematic literature review support the implementation or 
integration of telehealth interventions in the management of T2DM in the outpatient 
setting. Diabetes is a global health problem, and in the U. S. alone, the medical 
expenditure of diabetes is overwhelming (Olson et al, 2015). The results of this doctorate 
level project indicate that telehealth interventions can be implemented in urban areas, 
rural areas, to care for underserved or underinsured population with T2DM. This project 
also shows that telehealth interventions can increase access to care potentially reducing 
health disparities and improve care locally, nationally and internationally.  
Recommendations 
The findings of this systematic review indicate that the integration of telehealth 
interventions in the management of T2DM in the outpatient setting are promising in 
meeting the needs of these clients. According to the United Kingdom Prospective 
Diabetes Study (UKPDS), hgA1c remains the golden standard of controlling blood 
glucose in the long term (Zhou et al., 2014). Significantly reducing the number of face-
to-face visits means a significant saving of time and community resources, helping the 
already over-burdened primary care providers to still oversee the care of their patients 
from a distance. Further research is needed on the sustenance of decreases in hgA1c for 
periods exceeding 12 months in T2DM patients managed with telehealth interventions. 
Contributions of the Doctoral Project Team 
The doctoral project consisted mainly of the DNP student, a doctorate-prepared 
second reviewer, the project chair and committee members. The second reviewer 
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provided increased rigor to the systematic literature review by providing valuable insight 
into the analysis and synthesis of the articles. The project chair provided guidance and 
support, ensuring that the project was completed to meet the committee’s approval, and 
Walden University Institutional Review Board’s standards. 
Strength and Limitations of the Project 
The strength of this project was in reviewing the first account of studies involved 
in the use of telehealth as an intervention of choice in the management of T2DM. Perhaps 
including systematic reviews of RCTs would have increased the number of articles 
included in this project. Nonetheless the original studies reviewed provided credibility 
and rigor to this systematic review. One of the limitations of this study was the limiting 
of hgA1c as the only principal outcome measure. Inclusion of other metrics such as blood 
pressure, weight and low-density lipoprotein (LDL), are also important in the 
management of T2DM patients. Patient satisfaction and cost effectiveness of the 
interventions were not reviewed by this systematic literature review. 
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Section 5: Dissemination Plan 
Introduction 
Any research study is not complete without the dissemination of the study 
findings through the means of professional forum presentations or publishing in a peer-
reviewed journal to circulate them anywhere that the research findings can be translated 
into clinical practice (Curtis, Fry, Shaban & Considine, 2016). For this DNP study, plans 
for dissemination include submitting to ProQuest as part of the requirement for 
completion of the Doctor of Nursing Practice at Walden University. I also plan to reach 
out to various professional organizations such as Sigma Theta Tau and American Nursing 
Informatics Association in an effort to disseminate this project’s findings. I plan to also 
reach out to peer-reviewed journals such as Journal of Telehealth and Telecare and 
Journal of Clinical Nursing Practice, for a broader audience. I will also reach out to the 
evidence-based practice team at my place of employment for assistance in disseminating 
the project findings because even though telehealth is practiced at the site, it is not being 
used at its full potential. 
Analysis of Self 
Completing this systematic literature review afforded me the opportunity to put 
into practice the methods and principles learned throughout my time at Walden 
University. Performing this review was very labor-intensive requiring hours of searching 
databases for appropriate research articles, reading the articles, extracting data, 
appraising, synthesizing, and developing tables and charts to keep data organized. I have 
come to understand and appreciate the rigor that is involved in conducting research 
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studies, making sure that it is appropriate for use in clinical practice. Though I faced 
some challenges such as permission not being granted for completion of the project at a 
practicum site, I persevered, understanding that there is always the possibility of 
challenges in every project; finding ways or having contingency plans are essential in 
completing projects. The valuable skills, insights, and lessons learned gained from 
completing this systematic literature review will assist me to perform research studies in 
the future to enhance evidence-based practice and in my plan to teach and mentor nursing 
students. 
Summary 
With this systematic literature review I analyzed, synthesized, and presented the 
current evidence regarding the impact of telehealth in the management of T2DM in the 
outpatient setting. This study contributes to evidence-base practice by providing 
important information to further educate healthcare professionals on the many benefits of 
integrating telehealth interventions in the management of patients with T2DM. This 
project also brought to light the many telehealth interventions available to healthcare 
professionals to apply in the effort to improve the health outcomes of patients with 
T2DM by reducing the hemoglobin A1c. 
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Appendix A: A Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
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Appendix B: Joanna Briggs Institute Data Extraction Form for 
Experimental/Observational Studies 
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Appendix C: Joanna Briggs Institute Critical Appraisal Checklist for Randomized 
Controlled Trials 
JBI Critical Appraisal Checklist for Randomized Controlled Trials 
Reviewer     Date    
Author     Year  Record Number  
 Yes No Unclear NA 
1. Was true randomization used for assignment of participants to treatment 
groups? □ □ □ □ 
2. Was allocation to treatment groups concealed? □ □ □ □ 
3. Were treatment groups similar at the baseline? □ □ □ □ 
4. Were participants blind to treatment assignment? □ □ □ □ 
5. Were those delivering treatment blind to treatment assignment?  □ □ □ □ 
6. Were outcomes assessors blind to treatment assignment? □ □ □ □ 
7. Were treatment groups treated identically other than the intervention of 
interest? □ □ □ □ 
8. Was follow up complete and if not, were differences between groups in 
terms of their follow up adequately described and analyzed? □ □ □ □ 
9. Were participants analyzed in the groups to which they were randomized? □ □ □ □ 
10. Were outcomes measured in the same way for treatment groups? □ □ □ □ 
11. Were outcomes measured in a reliable way? □ □ □ □ 
12. Was appropriate statistical analysis used? □ □ □ □ 
13. Was the trial design appropriate, and any deviations from the standard RCT 
design (individual randomization, parallel groups) accounted for in the 
conduct and analysis of the trial? 
□ □ □ □ 
Overall appraisal:  Include  □ Exclude   □ Seek further info  □ 
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Comments (Including reason for exclusion) 
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Appendix D: Joanna Briggs Institute Critical Appraisal Checklist for Quasi-Experimental 
Studies 
JBI Critical Appraisal Checklist for Quasi-Experimental Studies  
(non-randomized experimental studies) 
Reviewer    Date     
 
Author     Year   Record Number       
 
 Yes No Unclear Not 
applicable 
14. Is it clear in the study what is the ‘cause’ and what is 
the ‘effect’ (i.e. there is no confusion about which 
variable comes first)? 
□ □ □ □ 
15. Were the participants included in any comparisons 
similar?  □ □ □ □ 
16. Were the participants included in any comparisons 
receiving similar treatment/care, other than the 
exposure or intervention of interest? 
□ □ □ □ 
17. Was there a control group? □ □ □ □ 
18. Were there multiple measurements of the outcome 
both pre and post the intervention/exposure? □ □ □ □ 
19. Was follow up complete and if not, were differences 
between groups in terms of their follow up 
adequately described and analyzed? 
□ □ □ □ 
20. Were the outcomes of participants included in any 
comparisons measured in the same way?  □ □ □ □ 
21. Were outcomes measured in a reliable way? □ □ □ □ 
22. Was appropriate statistical analysis used? □ □ □ □ 
Overall appraisal:  Include  □ Exclude   □ Seek further info  □ 
Comments (Including reason for exclusion) 
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Appendix E: Joanna Briggs Institute Critical Appraisal Checklist for Case Control 
Studies 
JBI Critical Appraisal Checklist for Case Control Studies  
 
Reviewer     Date      
 
Author      Year  Record Number        
 
 
 
Yes No Unclear 
Not 
applicab
le 
23. Were the groups comparable other than 
the presence of disease in cases or the 
absence of disease in controls? 
□ □ □ □ 
24. Were cases and controls matched 
appropriately? □ □ □ □ 
25. Were the same criteria used for 
identification of cases and controls? □ □ □ □ 
26. Was exposure measured in a standard, 
valid and reliable way? □ □ □ □ 
27. Was exposure measured in the same way 
for cases and controls? □ □ □ □ 
28. Were confounding factors identified?  □ □ □ □ 
29. Were strategies to deal with confounding 
factors stated? □ □ □ □ 
30. Were outcomes assessed in a standard, 
valid and reliable way for cases and 
controls? 
□ □ □ □ 
31. Was the exposure period of interest long 
enough to be meaningful? □ □ □ □ 
32. Was appropriate statistical analysis used? □ □ □ □ 
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Overall appraisal:  Include  □ Exclude   □ Seek further info  □ 
Comments (Including reason for exclusion) 
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Appendix I: Literature Matrix of Included Literature 
 
Authors/Year Aim/Study 
Objectives 
 
Methodology Telehealth 
Interventions/ 
Modalities 
Analysis & 
Results 
Level of 
Evidence 
Nicolucci, A., 
Cercone, S., 
Chiratti, A., 
Muscas, F., & 
Gensini, G. 
(2015). 
 
 
 
Using of a remote 
educational telehealth 
system in improving 
glycemic control and 
cardiovascular risk 
profile in patients 
with T2DM 
Randomized 
control trial 
Home telehealth 
using remote 
monitoring 
equipment and 
Telephone 
Over a period of 12 months, the 
use of this intervention method 
was associated with significant 
reduction in the average hgA1c 
levels compared to the control 
group. 
1c 
Orsama et al. 
(2013) 
 
 
 
Evaluation of a 
mobile telephone-
based remote patient 
monitoring system  
Randomized 
control trial 
Smart phone/ 
Application 
Intervention group achieved 
greater decline in hgA1c 
compared to control group 
(adjusted mean hgA1c of -0.40 
vs. -0.036). 
1c 
Cho et al. 
(2016). 
 
 
 
Improve glycemic 
control and evaluate 
the efficacy of an 
internet-based 
integrated health care 
system  
 
Randomized 
control trial 
with 
participants 
from 3 different 
health centers 
Internet-based 
modality 
HgA1c was significantly reduced 
at 6 months in the intervention 
group. Patients with baseline A1c 
<8.0% showed significant 
reduction in A1c at 6 months 
while the control group showed 
an increased tendency. 
1c 
Fortmann et 
al. (2017). 
 
Glycemic benefit and 
acceptance of a 
culturally tailored, 
Randomized 
control trial 
Smart phone/ 
Application 
At months 3 and 6 the 
intervention group showed 
1c 
68 
 
 SMS-based DSME 
and support in 
underserved 
Hispanics with poor 
control. 
significant decrease in mean 
hgA1c than control group. 
Warren, 
Carlisle, 
Mihala, & 
Scuffham 
(2017). 
 
 
 
Effect of tailored 
telemonitoring 
intervention on 
glycemic control and 
utilization of health 
services. 
Prospective 
randomized 
control trial 
Remote 
monitoring 
equipment 
Significant decrease in A1c. 
Intervention was effective in 
lowering A1c levels, helping 
T2DM patients move towards 
good control from poor control. 
 
1c 
Kempf et al. 
(2017). 
 
 
To test the hypothesis 
that participation in 
the TeLipro would be 
associated with 
improved A1c. 
Randomized 
control trial 
Internet-based 
modality 
A significant reduction in hgA1c 
was noted in the intervention 
group, at 12 weeks. 
 
1c 
Niemczewski, 
Polivka, & 
Clark (2016). 
Can follow up 
telephone calls after 
DSME class lead to 
reduction in A1c  
Quasi- 
experimental 
Telephone 
Intervention 
Both groups achieved reduction 
in A1c. Follow up calls were 
effective in helping patients stay 
on track with goals. 
2c 
Lim et al. 
(2016). 
Investigated use of 
individualized 
multidisciplinary u-
healthcare service in 
older adults with 
T2DM 
Randomized 
control trial 
Internet-based 
modality 
Statistically significant reduction 
in HgA1c and number of 
hypoglycemic events 
1c 
69 
 
Tang et al. 
(2013). 
Evaluated the 
Engaging and 
Motivating Patients 
Online for Diabetes 
(EMPOWER-D) that 
supports patients with 
T2DM 
Randomized 
control trial 
Internet-based 
modality 
Achieved and maintained a 
reduction in hgA1c at 6 months 
and 12 months 
1c 
Odnoletkova, 
Goderis, 
Nobels, 
Fieuws, 
Annermans, 
& Ramaekers. 
(2016). 
Effect of the COACH 
programme on hgA1c 
and other modifiable 
risks factors in 
patients with T2DM 
Randomized 
control trial 
Telephone 
intervention 
At 6 months significant decrease 
is noted in the hgA1c of the 
intervention while In the control 
group no change in hgA1c was 
noted. 
1c 
Greenwood, 
Blozis, 
Young, 
Nesbitt, & 
Quinn. 
(2015). 
Evaluate the 
effectiveness of a 
telehealth remote 
monitoring modality 
with paired glucose 
testing in adults with 
T2DM and non-
insulin dependent. 
Randomized 
control trial 
Remote 
monitoring 
intervention 
The intervention group showed 
significant decrease in hgA1c at 6 
months though both groups 
showed decrease in A1c, the 
control group at 6 months were 
no longer improving. 
1c 
Crowley et al. 
(2016). 
Feasibility and 
effectiveness of 
delivering Advanced 
Comprehensive 
Diabetes Care 
(ACDC) for 
persistent poorly 
Randomized 
control trial 
Telephone and 
remote 
monitoring 
interventions 
Significant improvement in mean 
hgA1c at 3 months and 6 months. 
The study concluded that this 
methodology improved hgA1c by 
1.0% which if sustained can 
reduce microvascular 
complications by 37%. 
1c 
70 
 
controlled diabetes 
mellitus (PPDM) 
Kim et al. 
(2016). 
Evaluated the 
efficacy of the 
IBGMS in controlling 
blood sugar in the 
Chinese population. 
Randomized 
control trial 
Internet-based 
modality 
Significant decrease in hgA1c 
was noted at 3 and 6 months. This 
system allows users to upload 
their glucose readings during their 
day-to-day lives. 
1c 
Threatt & 
Ward. (2017) 
To note any changes 
in hgA1c from 
baseline in a free 
clinic population 
participating in 
telehealth DSME/S 
services. 
Exploratory 
study design 
Clinical video 
telehealth (CVT) 
intervention 
Significant decrease in hgA1c 
was noted. Education was 
provided one on one via clinical 
video. 
3c 
Rasmussen, 
Lauszus, & 
Loekke 
(2016). 
Tested home 
treatment of T2DM 
by video consultation 
versus standard care 
in a randomized trial. 
Randomized 
control trial 
Clinical video 
telehealth (CVT) 
intervention 
A treatment algorithm was used 
and proven to be effective 
because both groups achieved 
individually planned goals. 
1c 
Wang et al. 
(2017). 
Evaluated the 
effectiveness and 
practicality of a 
model of internet-
based integrated 
management of 
diabetes. 
RCT Internet-based 
intervention 
At 3 months and 6 months mean 
hgA1c was significantly 
improved from baseline in both 
groups. Study noted feedback was 
very essential in reaching 
significant reduction in A1c. 
1c 
Istepanian et 
al. (2014). 
Feasibility study on 
using mobile phone 
technologies for type 
Case study Internet-based 
and Smart 
phone/app 
At the end of the intervention 
period, significant difference was 
noted in the mean hgA1c. 
4d 
71 
 
2 diabetes patients in 
Iraq. 
Zhou, Xu, 
Liu, Huang, 
Xu, &Chen 
(2014). 
Feasibility and 
effectiveness of an 
internet-based 
telemedicine system 
managing T2DM 
patients in China 
RCT Internet-based 
modality 
At 3 months there was significant 
change in the mean hgA1c of the 
intervention group compared to 
the control group. 
1c 
 
